These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 32620497

  • 1. Antifungal susceptibility of oral isolates of Candida species from chronic kidney disease patients on chronic dialysis.
    de la Rosa-García E, Olalde-Hernández MJ, Irigoyen-Camacho ME, Mondragón-Padilla A, Mendoza-Juache A, Sánchez-Vargas LO.
    J Mycol Med; 2020 Sep; 30(3):101009. PubMed ID: 32620497
    [Abstract] [Full Text] [Related]

  • 2. Oral colonisation and infection by Candida sp. in diabetic and non-diabetic patients with chronic kidney disease on dialysis.
    de la Rosa-García E, Miramontes-Zapata M, Sánchez-Vargas LO, Mondragón-Padilla A.
    Nefrologia; 2013 Nov 13; 33(6):764-70. PubMed ID: 24241363
    [Abstract] [Full Text] [Related]

  • 3. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct 13; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 13; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 5. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gaitán-Cepeda LA, Quindós G.
    Rev Iberoam Micol; 2005 Jun 13; 22(2):83-92. PubMed ID: 16107165
    [Abstract] [Full Text] [Related]

  • 6. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
    Yan Z, Young AL, Hua H, Xu Y.
    J Rheumatol; 2011 Nov 13; 38(11):2428-31. PubMed ID: 21844143
    [Abstract] [Full Text] [Related]

  • 7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Nov 13; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
    Miranda-Cadena K, Marcos-Arias C, Mateo E, Aguirre JM, Quindós G, Eraso E.
    Arch Oral Biol; 2018 Nov 13; 95():100-107. PubMed ID: 30096698
    [Abstract] [Full Text] [Related]

  • 9. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.
    Li YY, Chen WY, Li X, Li HB, Li HQ, Wang L, He L, Yang XP, Wang XC, Huang YL, Yao YG.
    BMC Infect Dis; 2013 Jan 28; 13():46. PubMed ID: 23356471
    [Abstract] [Full Text] [Related]

  • 10. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.
    AIDS; 1994 Jul 28; 8(7):945-50. PubMed ID: 7946104
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N, Alem N.
    Mikrobiyol Bul; 2016 Jan 28; 50(1):122-32. PubMed ID: 27058336
    [Abstract] [Full Text] [Related]

  • 14. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
    Jahanshiri Z, Manifar S, Moosa H, Asghari-Paskiabi F, Mahmoodzadeh H, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M.
    J Mycol Med; 2018 Jun 28; 28(2):361-366. PubMed ID: 29602636
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors.
    Paula SB, Morey AT, Santos JP, Santos PM, Gameiro DG, Kerbauy G, Sena EM, Ueda LT, Carneiro M, Pinge-Filho P, Yamauchi LM, Yamada-Ogatta SF.
    J Infect Dev Ctries; 2015 Dec 30; 9(12):1350-9. PubMed ID: 26719941
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.
    Ambe NF, Longdoh NA, Tebid P, Bobga TP, Nkfusai CN, Ngwa SB, Nsai FS, Cumber SN.
    Pan Afr Med J; 2020 Dec 30; 36():23. PubMed ID: 32774600
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.